A new survey of clinicians from 21 different countries has found a lack of consensus regarding the definition of familial amyotrophic lateral sclerosis. In addition, attitudes towards genetic testing vary greatly between practitioners. These attitudes must be changed if future therapeutic strategies are to succeed.
This is a preview of subscription content, log in via an institution to check access.
References
Vajda, A. et al. Genetic testing in ALS: a survey of current practices. Neurology 88, 991–999 (2017).
Dornblu¨th, O. An anatomical investigation of a case of amyotrophic lateral sclerosis. Neurol. Zbl. 13, 24–33 (in German) (1889).
Andersen, P. & Al Chalabi, A. Genetics of amyotrophic lateral sclerosis. What do we really know? Nat. Rev. Neurol. 7, 603–615 (2011).
Rohrer, J. D. et al. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 14, 291–301 (2015).
Freischmidt, A. et al. Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol. 74, 110–113 (2017).
Agosta, F. et al. The El Escorial criteria: strengths and weaknesses. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 1–7 (2015).
Ludolph, A. et al. A revision of the El Escorial criteria — 2015. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 291–292 (2015).
Weydt, P. et al. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Ann. Neurol. 79, 152–158 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ludolph, A. Genetic testing in amyotrophic lateral sclerosis. Nat Rev Neurol 13, 262–263 (2017). https://doi.org/10.1038/nrneurol.2017.48
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2017.48
- Springer Nature Limited